Direct-Acting Oral Anticoagulants (DOAC) Score
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Very Low0–3
- Low4–5
- Moderate6–7
- High8–9
The Direct-Acting Oral Anticoagulants (DOAC) Score calculates predicting bleeding risk in patients with atrial fibrillation on direct-acting oral anticoagulants. Key inputs include age category. Scores guide initiating guideline-directed medical therapy, antithrombotic or anticoagulant regimens, or urgent coronary angiography. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Predicts bleeding risk in patients with atrial fibrillation on direct-acting oral anticoagulants
Clinical Indication
The Direct-Acting Oral Anticoagulants (DOAC) Score is indicated for bedside clinical practice to support Predicts bleeding risk in patients with atrial fibrillation on direct-acting oral anticoagulants. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Adult patients presenting with suspected or established coronary artery disease, cardiac arrhythmias, congestive heart failure, or valvular heart defects. Clinical application is indicated across Emergency department, cardiac care unit (CCU), cardiac catheterization laboratory, and outpatient cardiology clinics.
Limitations & Contraindications
In hemodynamically unstable cardiogenic shock, cardiac arrest, or refractory acute coronary syndromes, immediate resuscitation and coronary angiography supersede scoring.
Clinical Pearls & Action Plan
Continuous 12-lead ECG monitoring, serial cardiac troponin measurements, and echocardiographic evaluation align with ESC/ACC/AHA clinical practice guidelines.
DOAC Score = Age points + Creatinine clearance points + Sum of risk factors (underweight, stroke/TIA/embolism history, diabetes, hypertension, antiplatelet use, NSAID use, bleeding history, liver disease). Maximum score is capped at 10 points.
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| age_category | string | Yes | Patient age category for bleeding risk assessment |
| creatinine_clearance_category | string | Yes | Creatinine clearance category |
| underweight | string | Yes | BMI <18.5 kg/m² |
| stroke_tia_embolism_history | string | Yes | History of stroke, TIA, or systemic embolism |
| diabetes | string | Yes | Diabetes mellitus |
| hypertension | string | Yes | Hypertension |
| antiplatelet_use | string | Yes | Current antiplatelet agent use (aspirin, clopidogrel, etc.) |
| nsaid_use | string | Yes | Current NSAID use |
| bleeding_history | string | Yes | History of major bleeding |
| liver_disease | string | Yes | Liver disease |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–3 | Very Low | Very low bleeding risk |
| 4–5 | Low | Low bleeding risk |
| 6–7 | Moderate | Moderate bleeding risk |
| 8–9 | High | High bleeding risk |
| 10–10 | Very High | Very high bleeding risk |
Evidence-Based References (EBM)
- Aggarwal A, Wang TY, Rumsfeld JS, et al. Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants. Circulation. 2023 Nov 7;148(19):1482-1492. doi: 10.1161/CIRCULATIONAHA.123.064556.DOI: 10.1161/CIRCULATIONAHA.123.064556
- Costa OS, Beyer-Westendorf J, Ashton V, et al. Performance of HAS-BLED and DOAC scores to predict major bleeding events in atrial fibrillation patients treated with direct oral anticoagulants: A report from a prospective European observational registry. Thromb Res. 2024 Aug;240:109063. doi: 10.1016/j.thromres.2024.109063.DOI: 10.1016/j.thromres.2024.109063